Introduction

ABOUT TREAT-NMD > INTRODUCTION > ABOUT TREAT-NMD

About TREAT-NMD

TREAT-NMD is a major initiative in the neuromuscular field that is creating the infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Since the network was launched in January 2007 our focus has been on the development of tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development and into the clinic, and on establishing best-practice care for neuromuscular patients worldwide.

Visit our industry section to find out how we are working with pharmaceutical and biotech companies to bring neuromuscular therapies to the clinic. Find out more about the diseases we cover here, or see our research section to learn more about the standard operating procedures, biobanks and other tools we are creating to improve preclinical research into these conditions.

 


TREAT-NMD Coordination Office: T: +44 191 241 8605 Fax: +44 191 241 8770 E:
FP6 Logo TREAT-NMD is supported through Priority 1 (Life Sciences, Genomics and Biotechnology for Health) of the European Union’s FP6 under contract number LSHM-CT-2006-036825 EU flag